Home › Funds › Chicago Capital Management, LLC › ESPR
Chicago Capital Management, LLC position in ESPR
ESPERION THERAPEUTICS INC NE
Chicago Capital Management, LLC reported holding 830,935 shares of ESPR (ESPERION THERAPEUTICS INC NE) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 2.48% of its reported portfolio and ranking #18 among its reported holdings. Chicago Capital Management, LLC has disclosed ESPR holdings in 3 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Chicago Capital Management, LLC's ESPR position evolved
Chicago Capital Management, LLC first disclosed a stake in ESPR in Q1 2025 at 7,500 shares (US$7.5M). Across 3 filings, Chicago Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 830,935 shares valued at US$2.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 7.50K | $7.49M | New |
| Q2 2025 | 7.50K | $7.42M | Hold |
| Q2 2026 | 830.93K | $2.61M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ESPR and 13F data
ESPR (ESPERION THERAPEUTICS INC NE) is a company whose sector is not yet classified in our data. 41 other funds we track also report a position in ESPR — the largest reported positions include GLAZER CAPITAL, LLC (US$70.8M), ODDO BHF ASSET MANAGEMENT SAS (US$15.8M), Beryl Capital Management LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ESPR
- GLAZER CAPITAL, LLC 22.42M sh · $70.84M · Q2 2026
- ODDO BHF ASSET MANAGEMENT SAS 5.00M sh · $15.80M · Q2 2026
- Beryl Capital Management LLC 4.43M sh · $14.00M · Q2 2026
- PenderFund Capital Management Ltd. 3.88M sh · $12.28M · Q2 2026
- PSquared Asset Management AG 3.30M sh · $10.43M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 2.96M sh · $9.34M · Q2 2026
- TIG Advisors, LLC 2.59M sh · $8.18M · Q2 2026
- GABELLI & Co INVESTMENT ADVISERS, INC. 2.32M sh · $7.32M · Q2 2026
- GARDNER LEWIS ASSET MANAGEMENT L P 1.37M sh · $4.31M · Q2 2026
More on Chicago Capital Management, LLC
FAQ
How long has Chicago Capital Management, LLC held ESPR?
Chicago Capital Management, LLC has disclosed ESPR holdings in 3 of the last 6 reported quarters, going back to Q1 2025.
What is Chicago Capital Management, LLC's current position in ESPR?
As of Q2 2026, Chicago Capital Management, LLC holds 830.93K shares of ESPR (ESPERION THERAPEUTICS INC NE), valued at $2.61M, representing 2.48% of its reported portfolio and ranking #18.
Has Chicago Capital Management, LLC been buying or selling ESPR?
In the latest 13F filing (Q2 2026), Chicago Capital Management, LLC newly opened its position in ESPR.
Which other funds hold ESPR?
Other major institutional holders of ESPR include GLAZER CAPITAL, LLC, ODDO BHF ASSET MANAGEMENT SAS, Beryl Capital Management LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.